IXC.AX
Price:
$0.12
Market Cap:
$9.02M
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Perth, Australia.
Industry
Biotechnology
IPO Date
2019-07-05
Stock Exchange
ASX
Ticker
IXC.AX
According to Invex Therapeutics Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -12.00. This represents a change of 203.99% compared to the average of -3.95 of the last 4 quarters.
The mean historical PE Ratio of Invex Therapeutics Ltd over the last ten years is -46.67. The current -12.00 PE Ratio has changed 2.47% with respect to the historical average. Over the past ten years (40 quarters), IXC.AX's PE Ratio was at its highest in in the June 2024 quarter at 2.40. The PE Ratio was at its lowest in in the June 2025 quarter at -13.97.
Average
-46.67
Median
-14.13
Minimum
-256.03
Maximum
-1.94
Discovering the peaks and valleys of Invex Therapeutics Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 413.34%
Maximum Annual PE Ratio = -1.94
Minimum Annual Increase = -91.51%
Minimum Annual PE Ratio = -256.03
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -14.13 | 413.34% |
| 2024 | -2.75 | 41.89% |
| 2023 | -1.94 | -79.39% |
| 2022 | -9.41 | -54.60% |
| 2021 | -20.73 | -4.60% |
| 2020 | -21.73 | -91.51% |
The current PE Ratio of Invex Therapeutics Ltd (IXC.AX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.27
5-year avg
-9.79
10-year avg
-46.67
Invex Therapeutics Ltd’s PE Ratio is less than Bio-Gene Technology Limited (-2.85), less than Vectus Biosystems Limited (-3.30), less than Memphasys Limited (-1.61), less than Percheron Therapeutics Limited (-0.48), less than Intelicare Holdings Limited (0), less than Chimeric Therapeutics Limited (-0.89), less than Biotron Limited (-10.32), less than Acrux Limited (-1.08), less than Cann Group Limited (-0.21), less than Adherium Limited (-0.33),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.85 | $7.93M | |
| -3.30 | $5.87M | |
| -1.61 | $9.82M | |
| -0.48 | $7.61M | |
| 0 | $10.52M | |
| -0.89 | $12.75M | |
| -10.32 | $4.98M | |
| -1.08 | $6.57M | |
| -0.21 | $5.63M | |
| -0.33 | $7.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invex Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invex Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Invex Therapeutics Ltd's PE Ratio?
How is the PE Ratio calculated for Invex Therapeutics Ltd (IXC.AX)?
What is the highest PE Ratio for Invex Therapeutics Ltd (IXC.AX)?
What is the 3-year average PE Ratio for Invex Therapeutics Ltd (IXC.AX)?
What is the 5-year average PE Ratio for Invex Therapeutics Ltd (IXC.AX)?
How does the current PE Ratio for Invex Therapeutics Ltd (IXC.AX) compare to its historical average?